HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens
US11918642B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2021 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Dec 15, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16234
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions for generating an immune response against human immunodeficiency virus (HIV) and their methods of uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.